Back to search results

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Cutaneous Squamous Cell Carcinoma · Skin Cancers - Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Charity L Ruhl, LPN) · ruhlcl@upmc.edu · 4126472013
    Contact: Study coordinator (Nicolena Verardi, PA-C) · verardin3@upmc.edu · 412-864-3682
    Contact: Principal Investigator (Oleg E Akilov, MD, PhD)
    Louis D Falo, MD, PhD (Sub-investigator)
    Melissa M Pugliano-Mauro, MD (Sub-investigator)
    Timothy Patton, DO (Sub-investigator)
    Jason Luke, MD (Sub-investigator)
    Nicolena Verardi, PA-C (Sub-investigator)
Study leads

  • Oleg E Akilov, MD, PhD

    Principal Investigator

    University of Pittsburgh

View source on ClinicalTrials.gov(opens in a new tab)